Air Products and Chemicals Total Cost of Revenue increased by 3.6% to $2.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $2.05B to $2.18B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 3.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.80B | $2.01B | $2.22B | $2.15B | $2.34B | $2.62B | $2.27B | $2.28B | $2.07B | $2.21B | $2.07B | $1.99B | $2.01B | $2.10B | $2.02B | $2.05B | $2.04B | $2.15B | $2.11B | $2.18B |
| QoQ Change | — | +11.3% | +10.8% | -3.2% | +8.9% | +11.9% | -13.3% | +0.5% | -9.3% | +6.6% | -6.3% | -3.7% | +0.7% | +4.9% | -4.2% | +1.9% | -0.7% | +5.2% | -1.8% | +3.6% |
| YoY Change | — | — | — | — | +30.0% | +30.6% | +2.2% | +6.1% | -11.6% | -15.8% | -9.0% | -12.8% | -3.1% | -4.7% | -2.5% | +3.1% | +1.7% | +2.0% | +4.5% | +6.4% |
| Segment | Q2 '26 |
|---|---|
| Americas | $959.50M |
| Asia | $561.60M |
| Europe | $508.90M |
| Corporate and other | $132.90M |
| Middle East and India | $21.50M |
| Total | $2.18B |